Human Tumor Procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis

R L Edwards; J Silver; F R Rickles; (for the Subcommittee)

doi:10.1055/s-0038-1651580

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1993; 69(02): 205-213
DOI: 10.1055/s-0038-1651580

Scientific and Standardization Committee Communication

Schattauer GmbH Stuttgart

Human Tumor Procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis

R L Edwards

The University of Connecticut School of Medicine and the American Red Cross Connecticut Region Blood Services, Farmington, CT, USA, and the Department of Veterans Affairs Medical Center, Newington, CT, USA

,

J Silver

The University of Connecticut School of Medicine and the American Red Cross Connecticut Region Blood Services, Farmington, CT, USA, and the Department of Veterans Affairs Medical Center, Newington, CT, USA

,

F R Rickles

The University of Connecticut School of Medicine and the American Red Cross Connecticut Region Blood Services, Farmington, CT, USA, and the Department of Veterans Affairs Medical Center, Newington, CT, USA

,

(for the Subcommittee)

› Institutsangaben

Abstract

als PDF herunterladen

PDF (1128 kb)

Referenzen

References
1 Edwards RL, Morgan DL, Rickies FR. Animal tumor procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemostas 1990; 63: 133-138
2 Edwards RL, Rickies FR. Leukocytes and tumor cells in thrombosis. In: Hemostasis and Thrombosis. Colman RW, Hirsh J, Marder VJ, Salzman EW. (eds) JB Lippincott; Philadelphia, PA: in press
3 Conkling PR, Greenberg CS, Weinberg JB. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood 1988; 72: 128-133
4 Cozzolino F, Torcia M, Miliani A, Carossino AM, Giordani R, Cinotti S, Filimberti E, Saccardi R, Bernabei P, Guidi G, DiGug-lielmo R, Pistoia V, Ferrarini M, Nawroth PP, Stern D. Potential role of Interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia. Am J Med 1988; 84: 240-250
5 Dover R, Goeting NLM, Taylor I, Roath OS, Francis JL. Factor X-activating activity in patients with colorectal carcinoma. Br J Surg 1987; 74: 1122-1124
6 Bastida E, Ordinas A, Escolar G, Jamieson GA. Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood 1984; 64: 177-184
7 Rana SV, Reimers HJ, Pathikonda MS, Bajaj SP. Expression of tissue factor and factor VII/tissue factor inhibitor activity in endotoxin or phorbal ester stimulated U937 monocyte-like cells. Blood 1988; 71: 259-262
8 Falanga A, Alessio MG, Donati MB, Barbui T. A new procoagulant in acute leukemia. Blood 1988; 71: 870-875
9 Donati MB, Gambacorti-Passerini C, Casali B, Falanga A, Vannotti P, Fossati G, Semeraro N, Gordon SG. Cancer procoagulant in human tumor cells: Evidence frr melanoma patients. Cancer Res 1986; 46: 6471-6474
10 Cajot JF, Kruithof EKO, Schleuning WD, Sordat B, Bachmann F. Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int J Cancer 1986; 38: 719-727
11 Mussoni L, Conforti G, Gambacorti-Passerini C, Alessio G, Pepe M, Vaghi M, Erba E, Amato G, Landoni F, Mangione C, Morasca L, Semeraro N, Donati MB. Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture. Eur J Clin Oncol 1986; 22: 373-380
12 Kitagawa H, Yamamoto N, Yamamoto K, Tanoue K, Kosaki G, Yamazaki H. Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells. Cancer Res 1989; 49: 537-541
13 Esumi N, Todo S, Imashuku S. Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line. Cancer Res 1987; 47: 2129-2135
14 Grignani G, Falanga A, Pachiarini L, Alessio MG, Zucchella M, Fratino P, Donati MB. Human breast and colon carcinomas express cysteine proteinase activities with pro-aggregating and pro-coagulant properties. Int J Cancer 1988; 42: 554-557
15 Wijermans PW, Rebel VI, Ossenkoppele GJ, Huijgens PC, Langenhuijsen MMAC. Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemia cells: reversal of the bleeding disorder by cell differentiation. Blood 1989; 73: 800-805
16 Curatolo L, Alessio G, Gambacorti-Passerini C, Casali B, Morasca L, Semeraro N, Donati MB. Procoagulant activity of mouse and human cultured cells following various types of transformation. Int J Cancer 1985; 35: 411-414
17 Guarini A, Gugliotta L, Timoncini C, Chetti L, Catani L, Russo D, Tura S. Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukemia. Scand J Haematol 1985; 34: 152-156
18 Chorba TL, Orenstein JM, Ney AB, Schwartz BS, Alabaster O, Kessler CM, Cohen P, Schulof RS. Phenotypic and ultrastructural characterization of a medullary thymocyte acute lymphoblastic leukemia with cellular procoagulant activity. Cancer 1985; 55: 675-681
19 Gralnick HR, Abrell E. Studies of the Procoagulant and the fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia. Br J Haematol 1973; 24: 89-99
20 Rickies FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 1983; 62: 14-31
21 Dvorak HF, Van DeWater L, Bitzer AM, Dvorak AM, Anderson D, Harvey VS, Bach R, Davis GL, DeWolf W, Carvalho ACA. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 1983; 43: 4334-4342
22 Hudig D, Bajaj SP. Tissue factor-like activity of the human monocytic tumor cell line U937. Thromb Res 1982; 27: 321-322
23 Sakuragawa N, Takahashi K, Hoshiyama M, Jimbo C, Ashizawa K, Matsuoka M, Ohnishi Y. The extract from the tissue of gastric cancer as procoagulant in disseminated intravascular coagulation syndrome. Thromb Res 1977; 10: 457-463
24 Ewan VA, Edwards RL, Rickies FR. Expression of procoagulant activity in a human monocyte like cell line. J Lab Clin Med 1983; 101: 401-410
25 Gordon SG, Cross BA. A factor X-activating cysteine protease from malignant tissue. Thromb Res 1975; 6: 127-137
26 Gordon SG, Gilbert LC, Lewis BJ. Analysis of PC A of intact cells from tissue culture. Thromb Res 1982; 26: 379-387
27 Pineo AF, Brain MC, Gallus AS, Hirsh J, Hatton MWC, Regoeczi E. Tumors, mucus production and hypercoagulability. Ann NY Acad Sci 1974; 230: 262-270
28 Sakuagawa N, Takahashi K, Hoshiyama M, Jimbo C, Matsuoka M, Onishi Y. Pathologic cells as procoagulant substance of disseminated intravascular coagulation in acute promyelocytic leukemia. Thromb Res 1976; 8: 263-273
29 Kinjo M, Oka K, Naito S, Kohga S, Tanaka K, Oboshi S, Hayaka Y, Yasumoto K. Thromboplastic and fibrinolytic activities of cultured human cancer cell lines. Br J Cancer 1979; 39: 15-23
30 O’Meara RAQ, Thornes RD. Some properties of the cancer coagulative factor. Irish J Med Sci 1961; 423: 106-112
31 Boggust WA, O’Brien DJ, O’Meara RAQ, Thornes RD. The coagulative factors of normal human and human cancer tissue. Irish J Med Sci 1963; 447: 131-144
32 Svanberg L. Thromboplastic activity of human ovarian tumours. Thromb Res 1975; 6: 307-313
33 Gordon SG, Franks JJ, Lewis BJ. Comparison of procoagulant activity in extracts of normal and malignant human tissue. J Natl Cancer Inst 1979; 62: 773-778
34 Karhumaki E, Saravo L, Helin H. Cells of the human myelomonocytic cell line RC2A synthesize tissue factor-like procoagulant and urokinase type plasminogen activator. J Leuk Biol 1987; 42: 36-42
35 Fair DS, MacDonald MJ. Cooperative interaction between factor VII and cell surface-expressed tissue factor. J Biol Chem 1987; 262: 11692-11698
36 Geczy CL, Jones A. Procoagulant induction by human lymphokine and interferon ϒ/PMA on a myelomonocytic cell line, RC2a. Br J Haematol 1988; 70: 211-218
37 Kornberg A, Treves A, Rachmilewitz EA, Fibach E. Generation of procoagulant activity (PCA) by phorbol-esters-induced macrophage derived from a leukemic promyelocytic cell line (HL60). Blood 1982; 59: 1061-1066
38 Grignani G, Jamieson GA. TF-dependent activation of platelets by cells and microvesicles of SK-OS-10 human osteogenic sarcoma cell line. Invasion Metastasis 1987; 7: 172-182
39 Gambarcorti-Passerini C, Semeraro N, Pourli MD, Gordon SG. Cancer procoagulant and haemostatic abnormalities in melanoma. Lancet 1986; 1: 920
40 Gouault-Heilmann M, Chadon E, Sultan C, Josso F. The procoagulant factor of leukemic promyelocytes. Demonstration of immunologic cross reactivity with human brain tissue factor. Br J Haematol 1975; 30: 151-158
41 Tanaka M. Induction of tissue factor like activity of human monoblastic leukemia cell line by tumor necrosis factor-alpha. Thromb Res 1989; 56: 201-211
42 Barrowcliffe TW, Marshall DE, Trickett LP, Hubbard AR, Gray E, Thorpe R. Procoagulant activity of T-lymphoblastoid cells in extrinsic and intrinsic coagulation systems. Thromb Haemostas 1989; 62: 880-894
43 Silberberg JM, Gordon S, Zucker S. Identification of tissue factor into pancreatic cancer cell lines. Cancer Res 1989; 49: 5443-5447
44 Viero P, Cortelazzo S, Barbui T, Semeraro N. Generation of procoagulant activity by hairy cells in response to endotoxin and phorbol esters. Eur J Clin Cancer Oncol 1986; 22: 857-862
45 Sakai T, Lund-Hansen T, Parborsky L, Pedersen AH, Kisiel W. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). J Biol Chem 1989; 17: 9980-9988
46 Kubota T, Andoh K, Sadakata H, Tanaka H, Kobayashi N. Tissue factor released from leukemic cells. Thromb Haemostas 1991; 65: 59-63
47 Donati MB, Falanga A, Consonni R, Alessio MG, Bassan R, Buelli M, Borin L, Catani L, Pogliani E, Gugliotta L. et al. Cancer procoagulant in acute non-lymphoid leukemia: relationship of enzyme detection to disease activity. Thromb Haemostas 1990; 64: 11-16
48 Alessio MG, Falanga A, Consonni R, Bassan R, Minetti B, Donati MB, Barbui T. Cancer procoagulant in acute lymphoblastic leukemia. Eur J Haematol 1990; 45: 78-81
49 Bauer KA, Conway EM, Bach R, Konigsberg WH, Griffin JD, Demetri G. Tissue gene expression in acute myeloblastic leukemia. Thromb Res 1989; 56: 425-430
50 Sakai T, Kisiel W. Binding of human factors X and Xa to HepG2 and J82 human tumor cells. J Biol Chem 1990; 265: 9105-9113
51 Parmar J, Taylor I, Roath S, Francis J. Procoagulant activity in whole blood from patients with breast and colorectal cancer. Blood Coag Fibrinolys 1990; 1: 127-132
52 el-Baruni K, Taylor I, Roath S, Francis JL. Factor X-activating procoagulant in normal and malignant breast tissue. Hematol Oncol 1990; 8: 323-332
53 Pacchiarini L, Meloni F, Zucchella M, Mangiarotti P, Tacconi F, Ballabio P, Grignani G. Proaggregating and procoagulant activities of human mesothelioma tumor cells at different stages of “in vitro” culture. Haematologica 1991; 76: 392-397
54 Celladurai M, Honn KV, Walz Da. HLA-DR is procoagulant. Biochem Biophys Res Commun 1991; 178: 467-473